基于床旁超声的脓毒症右心室功能障碍预后评估与危险因素分析
前瞻性观察研究纳入宁夏医科大学总医院ICU 2021年2月至2022年1月脓毒症及脓毒性休克患者116例,入ICU 24小时内以M型超声测TAPSE,<16 mm为SRVD组(24例,20.7%),≥16 mm为非SRVD组(92例,79.3%)。SRVD组急诊转入比例、感染部位≥2比例、APACHE II评分、SOFA评分、cTnI、Mb、CK-MB、NT-proBNP、SCr、乳酸更高,LVEF、PLT更低,使用去甲肾上腺素及CRRT比例更高。多因素Logistic回归显示LVEF(OR=0.918)、PLT(OR=0.990)、SCr(OR=1.008)、使用去甲肾上腺素(OR=15.198)为SRVD独立危险因素,并据此绘制列线图。SRVD组28天死亡率显著高于非SRVD组(41.7% vs 21.7%,P<0.05),机械通气时间有延长趋势但无统计学差异。
要点
- 脓毒症/脓毒性休克患者入ICU 24小时内TAPSE<16 mm者SRVD发生率20.7%(24/116),28天死亡率41.7%(10/24)vs 21.7%(20/92),P<0.05。
- 多因素Logistic回归:LVEF OR=0.918(95%CI 0.851-0.991,P=0.028)、PLT OR=0.990(95%CI 0.981-0.999,P=0.035)、SCr OR=1.008(95%CI 1.001-1.016,P=0.025)、使用去甲肾上腺素OR=15.198(95%CI 1.541-149.907,P=0.020)为SRVD独立危险因素。
- 列线图:LVEF 0.50计64分、SCr 100 μmol/L计18分、PLT 100×10^9/L计85分、使用去甲肾上腺素计39分;总分达253分时SRVD风险88%。
- SRVD组机械通气时间80.0(28.5,170.0)小时 vs 非SRVD组47.0(10.0,135.0)小时,P>0.05,无统计学差异。
- SRVD组急诊转入及感染部位≥2比例、APACHE II、SOFA、cTnI、Mb、CK-MB、NT-proBNP、SCr、乳酸更高,LVEF、PLT更低,使用去甲肾上腺素及CRRT比例更高。
适用人群与场景
- 纳入宁夏医科大学总医院ICU 2021年2月至2022年1月收治的脓毒症及脓毒性休克患者116例。
- 入ICU 24小时内以M型超声测量TAPSE,按TAPSE<16 mm分为SRVD组(24例)、≥16 mm分为非SRVD组(92例)。
诊断标准与关键阈值
- SRVD诊断依据床旁M型超声测得的TAPSE,TAPSE<16 mm定义为SRVD,TAPSE≥16 mm为非SRVD。
- SRVD风险列线图总分达253分时,SRVD风险为88%。
研究设计与关键结果
- 前瞻性观察研究,纳入脓毒症及脓毒性休克患者116例,SRVD 24例(20.7%),非SRVD 92例(79.3%)。
- SRVD组较非SRVD组:急诊转入及感染部位≥2比例更高,APACHE II评分、SOFA评分更高,cTnI、Mb、CK-MB、NT-proBNP、SCr、乳酸更高,LVEF、PLT更低,使用去甲肾上腺素及CRRT比例更高。
- 多因素Logistic回归:LVEF OR=0.918(95%CI 0.851-0.991,P=0.028)、PLT OR=0.990(95%CI 0.981-0.999,P=0.035)、SCr OR=1.008(95%CI 1.001-1.016,P=0.025)、使用去甲肾上腺素OR=15.198(95%CI 1.541-149.907,P=0.020)为SRVD独立危险因素。
- 列线图评分:LVEF 0.50计64分,SCr 100 μmol/L计18分,PLT 100×10^9/L计85分,使用去甲肾上腺素计39分;总分253分时SRVD风险88%。
- SRVD组机械通气时间80.0(28.5,170.0)小时 vs 非SRVD组47.0(10.0,135.0)小时,P>0.05;28天死亡率SRVD组41.7%(10/24)vs 非SRVD组21.7%(20/92),P<0.05。
证据类型、等级与局限
- 证据类型:前瞻性观察研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为脓毒症患者早期可能出现右心室功能障碍、肾功能损害及死亡率升高。
- 作者认为LVEF降低、PLT降低、SCr升高及使用去甲肾上腺素是脓毒症患者发生SRVD的独立危险因素。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To evaluate the prognosis of septic right ventricular dysfunction (SRVD) based on bedside ultrasound and explore its risk factors.
METHODS: A prospective observational study was conducted involving septic and septic shock patients admitted to the intensive care unit (ICU) of the General Hospital of Ningxia Medical University from February 2021 to January 2022. Tricuspid annular plane systolic excursion (TAPSE) was measured by M-mode ultrasound within 24 hours after ICU admission. According to the results of TAPSE, the subjects were divided into SRVD group (TAPSE < 16 mm) and non-SRVD group (TAPSE ≥ 16 mm). The gender, age, occurrence of septic shock, underlying diseases, source of patients, acute physiology and chronic health evaluation II (APACHE II) score, sequential organ failure assessment (SOFA) score, maximal body temperature within 24 hours after ICU admission, location and number of infections, duration of mechanical ventilation, and 28-day mortality were collected. Hemodynamic parameters, organ function indexes, oxygen therapy parameters and arterial blood gas analysis indexes were recorded within 24 hours after ICU admission. The differences of the above indexes between the two groups were compared. Binary multivariate Logistic regression analysis was used to screen out the independent risk factors for SRVD, and a nomogram of SRVD risk factors was drawn.
RESULTS: 116 patients with sepsis and septic shock were enrolled, of which 24 (20.7%) had SRVD and 92 (79.3%) had no SRVD. Compared with the non-SRVD group, the patients in the SRVD group had higher emergency transfer and infection site ≥ 2 ratio, APACHE II score, SOFA score, higher cardiac troponin I (cTnI), myoglobin (Mb), MB isoenzyme of creatine kinase (CK-MB), N-terminal pro-brain natriuretic peptide (NT-proBNP), serum creatinine (SCr), arterial blood lactic acid (Lac) and lower left ventricular ejection fraction (LVEF), platelet count (PLT) within 24 hours after ICU admission, and higher proportion of norepinephrine application and continuous renal replacement therapy (CRRT). Binary multivariate Logistic regression analysis showed that LVEF [odds ratio (OR) = 0.918, 95% confidence interval (95%CI) was 0.851-0.991, P = 0.028], PLT (OR = 0.990, 95%CI was 0.981-0.999, P = 0.035), SCr (OR = 1.008, 95%CI was 1.001-1.016, P = 0.025), and the usage of norepinephrine (OR = 15.198, 95%CI was 1.541-149.907, P = 0.020) were independent risk factors for SRVD in patients with sepsis and septic shock. Based on the above four independent risk factors, a nomogram of SRVD risk factors was drawn. The results showed that the score was 64 when LVEF was 0.50, 18 when SCr was 100 μmol/L, 85 when PLT was 100×109/L, and 39 when norepinephrine was used. When the total score reached 253, the risk of SRVD was 88%. Compared with non-SRVD group, the duration of mechanical ventilation in SRVD group was slightly longer [hours: 80.0 (28.5, 170.0) vs. 47.0 (10.0, 135.0), P > 0.05], and the 28-day mortality was significantly higher [41.7% (10/24) vs. 21.7% (20/92), P < 0.05].
CONCLUSIONS: Patients with sepsis may have right ventricular dysfunction, impaired renal function and increased mortality in the early stage. The decrease in LVEF and PLT, the increase in SCr and the application of norepinephrine are independent risk factors for SRVD in patients with sepsis.
参考来源
- Li H, Xu Y, Zhang X, et al. [Prognostic evaluation and risk factors analysis of septic right ventricular dysfunction based on bedside ultrasound]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2025. PMID: 41017177. doi:10.3760/cma.j.cn121430-20250204-00097
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。